These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21917339)

  • 21. A hopeless case?
    Woywodt A; Schneider G; Haller H; Hiss M
    Nephrol Dial Transplant; 2007 Apr; 22(4):1253-6. PubMed ID: 17267542
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: the effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation.
    Bastani B; Chu N
    Am J Nephrol; 1995; 15(6):468-72. PubMed ID: 8546167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How to start dialysis. Peritoneal dialysis--clinical aspects].
    Quarello F
    G Ital Nefrol; 2008; 25 Suppl 41():S25-6. PubMed ID: 18473316
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship between cytokines and tumour markers in patients with chronic heart failure.
    Kosar F; Aksoy Y; Ozguntekin G; Ozerol I; Varol E
    Eur J Heart Fail; 2006 May; 8(3):270-4. PubMed ID: 16309955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure.
    Vizzardi E; Nodari S; D'Aloia A; Chiari E; Faggiano P; Metra M; Dei Cas L
    Echocardiography; 2008 Oct; 25(9):955-60. PubMed ID: 18771557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment.
    Próchnicka A; Olszowska A; Baczyński D; Zelichowski G; Wańkowicz Z
    Pol Arch Med Wewn; 2009 Dec; 119(12):815-9. PubMed ID: 20010468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating levels of carbohydrate antigen 125 in chronic heart failure: Useful or futile?
    Morillas H; Núñez J; Moliner P
    Eur J Heart Fail; 2024 Apr; 26(4):803-805. PubMed ID: 38562007
    [No Abstract]   [Full Text] [Related]  

  • 28. CA 125 levels and left ventricular function in patients with end-stage renal disease on maintenance hemodialysis.
    Yilmaz H; Gürel OM; Celik HT; Sahiner E; Yildirim ME; Bilgiç MA; Bavbek N; Akcay A
    Ren Fail; 2014 Mar; 36(2):210-6. PubMed ID: 24289262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservative treatment of hydrothorax in a patient receiving peritoneal dialysis.
    Pipili C; Kiousi E; Ntenta E; Vasileiou K; Grapsa E
    Singapore Med J; 2017 Nov; 58(11):674-675. PubMed ID: 29167911
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure.
    Davutoglu V; Yildirim C; Kucukaslan H; Yuce M; Sari I; Tarakcioglu M; Akcay M; Cakici M; Ceylan N; Al B
    Kardiol Pol; 2010 Jul; 68(7):771-8. PubMed ID: 20648434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum tumor markers in patients on dialysis and kidney transplantation.
    Lye WC; Tambyah P; Leong SO; Lee EJ
    Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal dialysis in patients with heart failure.
    Van Der Sande FM; Cnossen TT; Cornelis T; Konings CJ; Kooman JP; Leunissen KM
    Minerva Urol Nefrol; 2012 Sep; 64(3):163-72. PubMed ID: 22971681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodialysis vs. peritoneal dialysis in chronic heart failure: getting to the heart of the matter.
    Pliquett RU; Girndt M
    Kidney Int; 2012 Jun; 81(12):1274-5; author reply 1275. PubMed ID: 22648361
    [No Abstract]   [Full Text] [Related]  

  • 34. The lower risk of de novo heart failure associated with peritoneal dialysis; the timing does matter.
    Kazory A
    Int J Cardiol; 2017 Feb; 229():122. PubMed ID: 27825729
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid.
    Turk HM; Pekdemir H; Buyukberber S; Sevinc A; Camci C; Kocabas R; Tarakcioglu M; Buyukberber NM
    Tumour Biol; 2003; 24(4):172-5. PubMed ID: 14654710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour biomarkers in heart failure: is there a role for CA-125?
    Yilmaz MB; Nikolaou M; Cohen Solal A
    Eur J Heart Fail; 2011 Jun; 13(6):579-83. PubMed ID: 21525015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The peritoneal ultrafiltration in patients with cardio-renal disease].
    Corciulo R; Corciulo S
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):86-103. PubMed ID: 28682031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Peritoneal dialyisis role in heart failure treatment, experience in our center].
    Díez Ojea B; Rodríguez Suárez C; Vidau P; Gago E; Díaz Molina B; Martín Fernández M; García Cueto C
    Nefrologia; 2007; 27(5):605-11. PubMed ID: 18045037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower risk of de novo congestive heart failure in peritoneal dialysis patients compared with hemodialysis patients.
    Wang IK; Lin CL; Sung FC
    Int J Cardiol; 2017 Feb; 229():123. PubMed ID: 27810291
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure.
    Kaya H; Kurt R; Beton O; Zorlu A; Yucel H; Gunes H; Oguz D; Yilmaz MB
    Tex Heart Inst J; 2017 Feb; 44(1):22-28. PubMed ID: 28265209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.